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 A new simple, sensitive, precise, economic and “green” spectrofluorimetric method for the 
determination of quinine both as a bulk drug and in tablet formulations was developed and validated using 
water as solvent. At a predetermined excitation wavelength (330 nm) and emission wavelength (380 nm), it 
was proved linear in the concentration range of 50-50  ng/mL, exhibited good correlation coefficient (R2= 
0.999) and excellent mean recovery (97.5-103%). The results of the recovery studies showed that the method 
was not affected by the presence of common excipients. The method was applied for the analysis of the drug in 
the pure, tablet and injectable forms. The method was validated for precision, accuracy and recovery studies. 
Limit of Detection and Limit of Quantification for quinine were found to be 16.6 ng/mL and 19.8 ng/mL 
respectively. The method has been successfully applied for the analysis of marketed formulations available in 
Senegal. 
© 2013 International Formulae Group. All rights reserved. 
 




Quinine (6-methoxycinchonan-9-ol) is 
a cinchona alkaloid that belongs to the aryl 
amino alcohol group of drugs. The discovery 
of quinine is considered the most 
serendipitous medical discovery of the 17th 
century (Keefe et al., 2012) and malaria 
treatment with quinine marked the first 
successful use of a chemical compound to 
treat an infectious disease (David and Jacob, 
2005). It has been used in medicine for ages 
and has been recognised anti-malaria 
properties. Quinine is also used for treatment 
of muscle cramps.  
In 1820, quinine was extracted from the 
bark of the cinchona tree of South America, 
isolated and named by Pierre Joseph Pelletier 
and Joseph Caventou. The purified quinine 
has then replaced the bark in the standard 
treatment of malaria (Dobson et al., 2001). It 
remained the antimalarial drug of choice until 
1940. Since then, many effective antimalarial 
drugs have been introduced, although quinine 
is still used to treat the disease in certain 
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critical circumstances, such as severe malaria, 
and in impoverished regions due to its low 
cost (Achan et al., 2011, Diener et al., 2002, 
Galloway et al., 1990, WHO, 1995). 
Moreover, quinine is very sensitive to 
ultraviolet light (UV) and will fluoresce in 
direct sunlight, due to its highly conjugated 
resonance structure as shown with the 
chemical structure in Figure 1. 
This native fluorescence is often 
exploited to analyse quinine. Several 
researchers have focused on the development 
of various analytical methods to determine 
quinine and chloroquine in biological fluids. 
These chromatographic methods include the 
use of normal-phase columns (Dua et al., 
1993) or reversed-phase columns (Galloway 
et al., 1990; Beru et al., 1990; Ducharme et 
al., 1997) after liquid-liquid extraction of the 
drugs (Croes et al., 1994; Dua et al., 1993) 
using UV detection (Galloway et al., 1990; 
Chmurzynski et al., 1997; Mberu et al., 1991; 
Babalola et al., 1993) or fluorescence 
detection (Chaulet et al., 1993; Croes et al., 
1994; Wanwimolruk, 1996). The latter is 
better for its greater sensitivity. 
Also, compendial methods to analyse 
quinine in pharmaceutical formulations 
already existed in Pharmacopoeias. The 
International Pharmacopeia published by 
World Health Organization described a 
titrimetric method (WHO, 1988). However, it 
is well known that titrimetric methods lack of 
specificity when compared to 
spectrofluorimetry for quantitative analysis.  
The United States Pharmacopea (USP) also 
published a liquid chromatographic (LC) 
method with UV detection (USP, 2011). 
Because of difficulties encountered to run this 
LC method successfully, our laboratory 
developed an optimised reversed phase LC 
method with UV detection to analyse drug 
formulations containing quinine (Diop et al., 
2009). 
To date and to our best knowledge, the 
methods described for the analysis of quinine 
in pharmaceutical formulations use organic 
solvents whose difficult removal threatens the 
environment and sustainable development 
especially in underdeveloped countries. In the 
present paper a simple, rapid, sensitive, 
accurate, specific, economical and 
reproducible method was developed and 
validated.  Since the drug was found to be 
freely soluble in water, this solvent was used 
to develop this spectrofluorimetric method for 
the determination of quinine as bulk drug and 




Figure 1: Chemical structure of Quinine. 
 
 
MATERIALS AND METHODS 
Reagents 
The quinine standard USP (Rockville, 
USA) and the Pharmaceutical grade excipients 
were provided by the Senegalese National 
Medicines Control Laboratory (LNCM, 39, 
Avenue Pasteur, Dakar). 
Five commercially available 
formulations codified A, B, C, D and E were 
purchased from local drugstores and analysed 
with this method. Distilled water produced in 
our laboratory with a distiller (GFL, 
Germany) was used to prepare the solutions. 
No organic solvent was used. Solutions were 
filtered through Whatman cellulose filter 
grade 42® (GE Healthcare, France).  
 
Apparatus 
A Perkin Elmer luminescence 
spectrometer model LS 45® (Perkin Elmer 
instruments, Massachusetts, USA) connected 
to a Fujitsu Siemens computer loaded with the 
FLwinlab® application software was used. All 
the measurements took place in a standard 10 
mm path-length quartz cell, thermo stated at 
25.0 ± 0.5 °C, with 10 mm bandwidth for the 
emission and excitation monochromators.  
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A Jasco UV/Vis spectrophotometer 
model V-570 (Jasco instruments, Tokyo, 
Japan) connected to an IBM computer loaded 
with the spectra manager application software 
was used. Working standards were scanned 
between 200-500 nm to choose the maximum 
wavelength absorbance.   
 
Preparation of standard stock and working 
solutions 
An amount of 5 mg quinine sulfate 
accurately weighed was transferred in 100 mL 
volumetric flask and dissolved with distilled 
water. A volume of 2 mL of this solution was 
again transferred in 200 mL volumetric flask 
and completed to the mark with distilled 
water. An aliquot of this stock standard 
solution (Qs) was further diluted with distilled 
water to get working standard solutions (Qw) 
of 50-100-200-250-300-400-500 ng/mL. 
 
Determination of excitation and emission 
wavelengths 
Excitation and emission wavelengths 
were respectively determined at 330 nm and 
380 nm, as described elsewhere (Ramseyer, 
2010; Boy and Telchid, 2007). Spectra data 




All experiments were performed in 
triplicate and the results were expressed as 
mean values ± standard deviations (SD). 
Relative standard deviations (RSD) were also 
determined. Statistical significance of 
differences was evaluated using Student’s t-
test and Fischer-Snedecor F-test at a 
confidence level of 95% (p<0.05). Excel 
software version 2007 (Windows XP) was 
used to analyse the data.  
Cochran’s test and Grubbs’ test were 
used to check for high standard deviations and 
for outlying means.  
 
Method validation 
The method was validated for the 
following parameters (linearity, precision, 
accuracy, selectivity, limit of quantification 
(LOQ) and limit of detection (LOD)) 
according to the International Conference 
Harmonization (ICH) guidelines (ICH, 2005; 
Swartz and Krull, 2012; Amarouche, 2012). 
Linearity and range 
 For linearity, five solutions at different 
concentration (50-100-200-250-300-400-500 
ng/mL) were prepared using seven different 
aliquots of Qs. The data were used for the 
linearity calibration plot. The limit of 
detection (LOD) and the limit of 
quantification (LOQ) were also calculated 
(ICH, 2005; CEAEQ, 2009; Sai et al., 2012; 
Swartz and Krull, 2012).  
Precision 
Intra-day precision (repeatability) and 
inter-day precision study (intermediate 
precision) of the method were assessed at 
three concentration levels (250, 300 and 400 
ng/mL) (n=3) against a qualified reference 
standard.  
The inter-day precision study was 
performed on three different days i.e day 1, 
day 2 and day 3 at three different 
concentration levels (250, 300 and 400 
ng/mL) (n=3). The relative standard 
deviations (RSD) values were calculated.  
Stability studies 
Samples prepared for stability studies 
were preserved for 48 h at room temperature 
and were analysed the following day to test 
the short-term stability (Maleque et al., 2012). 
Accuracy and recovery studies 
Accuracy was determined by the 
recovery studies in the formulation of quinine. 
Recovery studies were carried out by addition 
of known quantities of standard drug solution 
to pre-analysed sample at five different 
concentrations.  
The percentage recoveries were 
calculated. Accuracy was expressed as 
relative errors which can be calculated by the 
equation:  
Relative error(%)=
Mean determined value – Theoretical (added amount)
Theoretical  
 
Specificity in the presence of excipients 
The test for the specificity was carried 
out using only excipients. Spectra for placebo 
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granules, blank, and sample were compared in 
order to verify interference (Maleque et al., 
2012). 
 
Assay of content of Quinine in selected 
marketed brands 
Five market brands of quinine tablets 
or bolus were selected at random and analysed 
using the newly developed and validated 
method. The powder or suspension of Quinine 
was accurately weighed or measured and 
transferred to 200 mL volumetric flask and 
made up to the mark with distilled water. The 
solution was shaken for 20 min. The resulting 
solution was further diluted with distilled 
water and filtered through whatman cellulose 
filter grade 42. A volume of 1 mL of the 
above solution was pipetted out into 200 mL 
and 100 mL volumetric flask and made up to 
the mark with distilled water. The 
fluorescence was measured against the blank. 
The amount of the drug in a sample was 
calculated from the calibration curve using the 
following equation: 
CQ(%)= Cexpx 200(mL) x 200 x
P
Ws x Wst 100
W CFx x
 
Where CQ is the content of quinine per 
tablet(%), Cexp is the found concentration 
based on the fluorescence intensity (ng/mL), 
Ws is the weight of generic sample powder 
(g), Wst is the weight of quinine base 
reference standard powder (g), W  is the 
average weight of tablet (g), P is the potency 
of quinine standard and CF is the conversion 




Method development and optimisation 
Quinine is freely soluble in aqueous 
medium at concentration much higher than 
our working and stock solutions. During the 
development phase, the maximum absorption 
wavelength appeared at 330 nm (Figure 2) 
while the maximum excitation and emission 
wavelengths appeared respectively at 330 nm 
and 380 nm (Figure 3).  
In all cases the analysis time did not exceed 
five minutes.  
 
Method validation 
Linearity and range 
The calibration curve was linear over 
the concentration range 1-500 µg/mL and the 
regression equation was found to be y = 0.957 
x + 14.558 with correlation coefficient (R2) of 
0.999. The LOD and LOQ were calculated as 
16.6 ng/mL and 19.8 ng/mL respectively.  
Intra-day and inter-day precision studies 
The RSD in precision studies was 
found to be 0.05-0.3% (Intra-day) and 0.50-
1.58% (Inter-day) (Table 1).  
Stability studies 
Table 2 shows the short-term stability 
study results which are in the acceptance 
range over 48h.  
 
Accuracy/recovery studies 
The RSD in accuracy studies was 
calculated at each concentration levels and 
was found to be less than 0.5% (Table 3).  
Also relative error (inaccuracy) values ranged 
from -2.5% to 3% as shown in Table 3. 
 
Specificity in the presence of excipients 
Figure 3 shows spectra of fluorescence 
(with their different parts) of pure quinine (a), 
quinine in the presence of excipients (b) and 
excipients mixture (c).  
 
Assay of content of Quinine in selected 
marketed brands 
The proposed method was applied to 
the determination of quinine tablets (sample A 
to D) and injectable quinine (sample E) 
selected at random.  The results of these 
assays yielded 98.58 % to 101% for tablets 
and 93.51% for the sample of injectable 
quinine (Table 4). All RSDs were less than 
1%.  
The main characteristics of the 
developed method are summarized in Table 5. 
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Table 1: Intra-day and inter-day precision determined for three different concentrations of quinine 
(n=3). 
 





   
inter-day 
precision 
   Declared 
concentrati
on (ng/mL) 












250 256.96 ± 0.13 0.05 102.79  254.37 ± 2.90 1.14 101.75  
300 307.04 ± 0.29 0.09 102.35  305.38 ± 1.55 0.50 101.79  





Table 2: Short-term stability determined by the proposed method (n=3). 
 
short-term stability determined by the proposed method (n=3) 
Concentration found    
Declared concentration (ng/mL) (Mean ± SD ng/mL) RSD (%) Averagepotency (%) 
50 51.41 ± 0.97 1.89 
100 94.95 ± 1.05 1.11 






















60 156.00 ± 0.17 0.11 -2.5 97.5 
80 185.40 ± 0.24 0.13 3.0 103.0 
100 196.60 ± 0.20 0.10 -1.7 98.3 
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Mean SD RSD (%)  Mean 
1 A 250 246.45 0.08 0.03  98.58 
2 B 120 119.51 0.04 0.03  99.59 
3 C 250 252.47 0.04 0.01  101.00 
4 D 120 120.02 0.06 0.05  100.02 
5 E 59.30 55.45 0.36 0.65  93.51 
 
 
Table 5: Main characteristics of the proposed method. 
 
λex(nm)/λem(nm) 330/380 
Intra-day precision (% RSD) 0.05-0.33 
Inter-day precision (% RSD) 0.50-1.14 
Linearity range (ng/mL) 50-500 
Accuracy (% recovery) 97.5-103 
Regression equation Y=0.957X +14.558 
Slope 0.957 
Intercept 14.558 
Correlation coefficient 0.999 
LOD (ng/mL) 16.6 














Figure 2: UV spectrum of  quinine. 
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The correlation coefficient of 0,999 
means that the method is linear (Samanidou et 
al., 2005; Maleque et al., 2012; Amarouche., 
2012, Swartz and Krull, 2012). The two 
concentration limits are measured under 
repeatability conditions (n=6). The ration of 
the two variances (Fcalc) is compared with F0,99 
(Snedecor law) (Gonzalez et al., 2007). Since 
Fcalc (5,32) < F0,99 (10,67), the linearity range 
is acceptable (Gonzalez et al., 2007). A good 
linear relationship was observed in the 
concentration range of 1-500 ng/mL. The 
slope of 0.957 and the low limits of detection 
and quantification reaching both nanogram 
per liter indicate clearly that the developed 
method is very sensitive. These results are in 
accordance with the sensitivity of fluorimetric 
analytical techniques (Royer, 1995). It can be 
concluded that the developed method is 
sensitive. 
Since Ccalc (0.38) < C0,99 (0.88), the 
Cochran’s test revealed no high standard 
deviations. Also, since Gcalc < G0,99 (1.97) (for 
all means at each concentration level), the 
Grubbs’ test showed no outlying means. 
Results within the range of 97.5% - 
103% ensure an accurate method (Maleque et 
al., 2012). Also relative error (inaccuracy) 
values ranging from -2.5% to 3.0% as shown 
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in table 3 can be considered as excellent and 
indicate a lack of interference with the 
excipients of formulations. No significant 
difference was observed between the mean 
values of amounts added and found (p > 0.05). 
Also Student’s t-test for significance of slope 
(0,957) and interceipt (14.558) revealed no 
interference. It can be concluded that the 
method is specific (Maleque et al., 2012). The 
results obtained were reproducible with 
excellent percentage recoveries and low RSD 
values. 
Figure 2 shows the UV absorption 
spectrum of pure quinine while Figure 3 
shows spectra of fluorescence of pure quinine 
(Figure 3a), quinine in presence of excipients 
(Figure 3b) and excipients mixture (Figure 
3c). No fluorescence was noted with 
excipients (Figure 3c) at the maximum 
emission wavelength (380 nm). The 
fluorescence curve at 380 nm (specific to 
Quinine) appears only in Figures 3a and 3b as 
expected. For the Figures 3a, 3b and 3c, the 
curve at the excitation wavelength (330 nm) is 
known as Raman scattering and due to 
inelastic scattering in solvents. This curve is 
always close to the curve known as Rayleigh 
scattering (elastic scattering) always more 
intense (Rouessac et al., 2009). The result 
shown in Figure 3c is in accordance with 
excipients chemical structures. Then the 
developed method is accurate and specific for 
the analysis of drugs without prior extraction. 
The high sensitivity and selectivity of 
this technique made possible the development 
of many applications, particularly in the field 
of analysis of medicinal natural substances 
and their metabolites in biological fluids 
(Samanidou et al., 2005). 
Low values of RSD ranging from 
0.08% to 0.15% also indicate the suitability of 
this method for the analysis of quinine 
formulation and commercially available 
dosage forms (tablets and injection). 
The RSD in precision studies was 
found to be 0.05-0.33% (Intra-day) and 0.50-
1.58% (Inter-day) (Table 1). The intra-day 
and inter-day precision studies (Table 1) of 
the developed method confirmed adequate 
sample stability and method reliability where 
all the RSDs were < 2%.  These results clearly 
indicate that the method is precise enough for 
the analysis of the drug.  
Table 2 shows the short-term stability 
study results which are in the acceptance 
range over 24h. Stability studies were in the 
acceptance range (Table 2) with average 
potencies ranged from 94.95% to 102.82% 
with RSD < 2% at each level, after one day 
storage at room temperature (Maleque et al., 
2012). 
The Quinine content of five marketed 
products (four tablets samples coded A to D 
and one injectable sample coded E) evaluated 
with this new method was in good agreement 
with the label claims and the Pharmacopeia’s 
specifications (WHO, 1988; USP, 2011).  The 
results of these assays yielded 98.58% -101% 
for tablets and 93.51% for the injectable 
quinine sample. All calculated RSDs values 
were less than 1%. These values meet official 
requirements (ICH, 2005) and many authors 
considered that these values are very 
satisfactory (Samanidou et al., 2005; Maleque 
et al., 2012; Swartz and Krull, 2012). 
To our best knowledge, this analytical 
fluorimetric method is the first method using 
water as exclusive solvent without any trace 
of organic solvent. Such a method can be 
called “green analytical technique”.  
The developed fluorimetric method is 
simple, accurate, precise and selective for the 
estimation of quinine in solid and suspension 
forms.  The high percentage recoveries 
obtained in Table 4 for various amounts of 
quinine in formulated mixture with excipients 
(such as starch, gelatin, gum arabic and talc) 
suggested that there is no interference. 
Evidence is made by the lack of absorbance at 
the specified wavelength for the excipients 
and blank solutions.  
Several studies have described various 
problems related to the quality of quinine drug 
(Lon et al., 2006; Kayumba  et al., 2004; 
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Evans et al., 2012; Pribluda et al., 2012). In 
this context, national drug regulators need to 
strengthen their roles in the monitoring of 
anti-malarial drug quality using simple, 
economical and precise analytical methods 
like this newly developed method. 
 
Conclusion 
The proposed method is simple and 
precise and do not suffer from any 
interference due to common excipients of 
marketed drugs. The method is linear in the 
concentration range of 50-500 ng/mL. 
Futhermore, the limit of detection, the 
simplicity of the procedure and the short 
analysis time (approximately 5 min) in 
comparison with the already published 
methods should allow this method to be a 
useful tool for the routine analysis of quinine. 
In developing countries, substandard drugs are 
a major concern in the management of 
malaria.This method can easily be used for 
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